Ocelot Bio Revenue and Competitors
Estimated Revenue & Valuation
- Ocelot Bio's estimated annual revenue is currently $2.2M per year.
- Ocelot Bio's estimated revenue per employee is $77,500
Employee Data
- Ocelot Bio has 29 Employees.
- Ocelot Bio grew their employee count by 32% last year.
Ocelot Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Clinical Development and Study Management | Reveal Email/Phone |
2 | VP, Regulatory Affairs and Quality | Reveal Email/Phone |
Ocelot Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Ocelot Bio?
Ocelot Bio is a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics designed to significantly improve outcomes for patients with liver disease. The company’s lead clinical candidate, OCE-205, is a peptide therapeutic with a mechanism of action designed to selectively target complications of portal hypertension, such as hepatorenal syndrome with acute kidney injury (HRS-AKI), a serious and life-threatening consequence of end-stage liver disease (ESLD). Ocelot Bio plans to initiate a Phase 2 clinical trial of OCE-205 in the first half of 2022 in HRS-AKI, for which there has been no therapeutic drug innovation in over two decades. The company was founded by leading experts in peptide therapeutic development and is backed by a strong syndicate of investors including Venrock Ventures, RA Capital Management and Vivo Capital. For more information, visit www.ocelotbio.com.
keywords:N/A
N/A
Total Funding
29
Number of Employees
$2.2M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2M | 29 | 4% | $8.9M |
#2 | $2.5M | 29 | N/A | N/A |
#3 | $5.1M | 29 | -3% | N/A |
#4 | $2.2M | 29 | -47% | $77M |
#5 | $3.5M | 29 | -17% | N/A |